Other Species / Isoforms
  STAT6 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2-p
______MsLWGLVsk
0 2
STAT6 (human) ______MsLWGLVsk S2-p
STAT6 iso2 (human) gap -
STAT6 (mouse) ______MSLWGLISK S2
STAT6 (rat) ______MSLWSLVSK S2
S8-p
MsLWGLVskMPPEKV
Upstream
0 2
Treatment
  • nocodazole
STAT6 (human) MsLWGLVskMPPEKV S8-p
STAT6 iso2 (human) gap -
STAT6 (mouse) MSLWGLISKMSPEKL S8
STAT6 (rat) MSLWSLVSKMSPEKL S8
K9-ub
sLWGLVskMPPEKVQ
0 1
STAT6 (human) sLWGLVskMPPEKVQ K9-ub
STAT6 iso2 (human) under review -
STAT6 (mouse) SLWGLISKMSPEKLQ K9
STAT6 (rat) SLWSLVSKMSPEKLQ K9
R27
VDFPQHLRHLLGDWL
1 0
STAT6 (human) VDFPQHLRHLLGDWL R27
STAT6 iso2 (human) gap -
STAT6 (mouse) VDFPQRLrHLLADWL R27-me
STAT6 (rat) VDFPQHLRHLLAEWL R27
K94
IYQRDPLKLVATFRQ
0 1
STAT6 (human) IYQRDPLKLVATFRQ K94
STAT6 iso2 (human) gap -
STAT6 (mouse) IYQRDPLkLVATIRQ K94-ub
STAT6 (rat) IYQRDPLKLVATIRQ K94
K129
HWKQEELKFKTGLRR
0 1
STAT6 (human) HWKQEELKFKTGLRR K129
STAT6 iso2 (human) gap -
STAT6 (mouse) HRKQEELkFTTALGR K129-ac
STAT6 (rat) HRKQEELKFTTALGR K129
K277-ub
TSCFLVEkQPPQVLK
0 2
STAT6 (human) TSCFLVEkQPPQVLK K277-ub
STAT6 iso2 (human) TSCFLVEKQPPQVLK K103
STAT6 (mouse) TSSFLVEkQPPQVLK K277-ub
STAT6 (rat) TSSFLVEKQPPQVLK K277
K288-ub
QVLKTQTkFQAGVRF
0 1
STAT6 (human) QVLKTQTkFQAGVRF K288-ub
STAT6 iso2 (human) QVLKTQTKFQAGVRF K114
STAT6 (mouse) QVLKTQTKFQAGVRF K288
STAT6 (rat) QVLKTQTKFQAGVRF K288
K307-ub
RFLGAPAkPPLVRAD
0 2
STAT6 (human) RFLGAPAkPPLVRAD K307-ub
STAT6 iso2 (human) RFLGAPAKPPLVRAD K133
STAT6 (mouse) QFLGTSAKPPMVRAD K307
STAT6 (rat) QFLGTSAKPPLVRAD K307
K319-ub
RADMVTEkQARELSV
0 2
STAT6 (human) RADMVTEkQARELSV K319-ub
STAT6 iso2 (human) RADMVTEKQARELSV K145
STAT6 (mouse) RADMVTEKQARELSL K319
STAT6 (rat) RADMVTEKQARELSL K319
S407-p
PIQLQALsLPLVVIV
Upstream
1 0
Putative in vivo kinases:
  • TBK1 (human)
Treatment
  • virus infection
STAT6 (human) PIQLQALsLPLVVIV S407-p
STAT6 iso2 (human) PIQLQALSLPLVVIV S233
STAT6 (mouse) LIQLQALSLPLVVIV S407
STAT6 (rat) LIQLQALSLPLVVIV S407
K450-ub
AERVPWEkMCETLNL
0 1
STAT6 (human) AERVPWEkMCETLNL K450-ub
STAT6 iso2 (human) AERVPWEKMCETLNL K276
STAT6 (mouse) AERVPWEKMCETLNL K450
STAT6 (rat) AERVPWEKMCETLNL K450
K504-ub
VSWSQFNkEILLGRG
0 1
STAT6 (human) VSWSQFNkEILLGRG K504-ub
STAT6 iso2 (human) VSWSQFNKEILLGRG K330
STAT6 (mouse) VSWSQFNKEILLGRG K504
STAT6 (rat) VSWSQFNKEILLGRG K504
T525-p
FDGVLDLtKRCLRSY
0 1
STAT6 (human) FDGVLDLtKRCLRSY T525-p
STAT6 iso2 (human) FDGVLDLTKRCLRSY T351
STAT6 (mouse) FDGVLDLTKRCLRSY T525
STAT6 (rat) FDGVLDLTKRCLRSY T525
K595-ub
NIQPFSAkDLSIRSL
0 2
STAT6 (human) NIQPFSAkDLSIRSL K595-ub
STAT6 iso2 (human) NIQPFSAKDLSIRSL K421
STAT6 (mouse) NIQPFSAkDLSIRSL K595-ub
STAT6 (rat) NIQPFSAKDLSIRSL K595
K613-ub
IRDLAQLkNLYPKKP
0 1
STAT6 (human) IRDLAQLkNLYPKKP K613-ub
STAT6 iso2 (human) IRDLAQLKNLYPKKP K439
STAT6 (mouse) IRDLAQLKNLYPKkP K613
STAT6 (rat) IRDLAQLKNLYPKKP K613
K619
LkNLYPKKPKDEAFR
0 1
STAT6 (human) LkNLYPKKPKDEAFR K619
STAT6 iso2 (human) LKNLYPKKPKDEAFR K445
STAT6 (mouse) LKNLYPKkPkDEAFR K619-ac
STAT6 (rat) LKNLYPKKPKDEAFR K619
K621
NLYPKKPKDEAFRSH
0 1
STAT6 (human) NLYPKKPKDEAFRSH K621
STAT6 iso2 (human) NLYPKKPKDEAFRSH K447
STAT6 (mouse) NLYPKkPkDEAFRSH K621-ac
STAT6 (rat) NLYPKKPKDEAFRSH K621
Y641-p
MGKDGRGyVPAtIKM
Upstream
16 95
STAT6 (human)
Y641-p
STAT6 iso2 (human)
Y467-p
STAT6 (mouse)
Y641-p
STAT6 (rat)
Y641-p
Putative upstream phosphatases:
  • PTPN13 (human)
Regulatory protein:
  • NPM-ALK (human)
Treatment
  • hypoxia
  • IL-17A
  • IL-6
  • virus infection
STAT6 (human) MGKDGRGyVPAtIKM Y641-p
STAT6 iso2 (human) MGKDGRGYVPATIKM Y467
STAT6 (mouse) MGKDGRGyVSTTIKM Y641-p
STAT6 (rat) MGKDGRGyVSTTIKM Y641-p
T645-p
GRGyVPAtIKMTVER
0 2
STAT6 (human) GRGyVPAtIKMTVER T645-p
STAT6 iso2 (human) GRGYVPATIKMTVER T471
STAT6 (mouse) GRGyVSTTIKMTVER T645
STAT6 (rat) GRGyVSTTIKMTVER T645
S707-p
IPPYQGLsPEESVNV
Upstream
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, inhibited
Kinase, in vitro:
  • JNK1 (human)
Putative in vivo kinases:
  • JNK1 (human)
Treatment
  • anisomycin
  • IFN-gamma
  • IL-1b
  • siRNA
  • SP600125
STAT6 (human) IPPYQGLsPEESVNV S707-p
STAT6 iso2 (human) IPPYQGLSPEESVNV S533
STAT6 (mouse) gap -
STAT6 (rat) IHSFQSIPLEESMSV P702
S756-p
PQEHAVSsPDPLLCS
Upstream
1 0
Treatment
  • IL-4
STAT6 (human) PQEHAVSsPDPLLCS S756-p
STAT6 iso2 (human) PQEHAVSSPDPLLCS S582
STAT6 (mouse) SQEHAVSSPEPMLCS S747
STAT6 (rat) SQEHAVSSPEPLLCS S751
S817-p
QGESGGGsLGAQPLL
0 1
STAT6 (human) QGESGGGsLGAQPLL S817-p
STAT6 iso2 (human) QGESGGGSLGAQPLL S643
STAT6 (mouse) NQGEAGGSLGSQPLL S807
STAT6 (rat) GQGEGGGSIGTQPLL S811